TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IBIO

iBio, Inc.

Healthcare · Biotechnology

1.20$ -1.7% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns iBio, Inc. (IBIO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 81.0% of the shares are freely tradable; institutional investors hold 49.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 49.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 81.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 8.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 64Mio.

Largest Shareholders

Institutions

Institutions IBIO
Name Stake (%) Shares Change (%) Date
Affinity Asset Advisors, LLC 13.34 4,007,881 +29.0 06/30/2026
Frazier Life Sciences Management, L.P. 6.50 1,953,467 +0.0 03/31/2026
Millennium Management LLC 5.50 1,651,473 +6.6 06/30/2026
Citadel Advisors Llc 4.61 1,384,029 +44.7 06/30/2026
Vanguard Capital Management, LLC 3.62 1,088,299 +0.0 03/31/2026
Balyasny Asset Management LLC 3.36 1,010,955 -7.8 03/31/2026
Ikarian Capital, LLC 3.18 957,062 +0.0 03/31/2026
Sio Capital Management, LLC 3.01 904,268 +0.0 06/30/2026
Marshall Wace Asset Management Ltd 2.07 620,602 +411.7 03/31/2026

Funds

Funds IBIO
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.28 1,465,833 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?